Annual Cash & Cash Equivalents
$29.99 M
-$5.05 M-14.42%
December 31, 2021
Summary
- As of February 8, 2025, ALNA annual cash & cash equivalents is $29.99 million, with the most recent change of -$5.05 million (-14.42%) on December 31, 2021.
- During the last 3 years, ALNA annual cash & cash equivalents has fallen by -$31.66 million (-51.35%).
Performance
ALNA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.59 M
-$2.31 M-25.92%
June 30, 2022
Summary
- As of February 8, 2025, ALNA quarterly cash and cash equivalents is $6.59 million, with the most recent change of -$2.31 million (-25.92%) on June 30, 2022.
- Over the past year, ALNA quarterly cash and cash equivalents has dropped by -$20.07 million (-75.28%).
Performance
ALNA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ALNA Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.4% | -75.3% |
3 y3 years | -51.4% | -86.4% |
5 y5 years | -68.3% | -81.0% |
ALNA Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | at low | -78.0% | at low |
5 y | 5-year | -14.4% | at low | -83.7% | at low |
alltime | all time | -68.3% | -15.8% | -93.0% | at low |
Allena Pharmaceuticals Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $6.59 M(-25.9%) |
Mar 2022 | - | $8.89 M(-70.3%) |
Dec 2021 | $29.99 M(-14.4%) | $29.99 M(-25.8%) |
Sep 2021 | - | $40.42 M(+51.6%) |
Jun 2021 | - | $26.66 M(-26.5%) |
Mar 2021 | - | $36.29 M(+3.6%) |
Dec 2020 | $35.04 M(+16.8%) | $35.04 M(+16.3%) |
Sep 2020 | - | $30.14 M(+13.9%) |
Jun 2020 | - | $26.45 M(+29.3%) |
Mar 2020 | - | $20.45 M(-31.8%) |
Dec 2019 | $30.01 M | $30.01 M(-23.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $39.42 M(-18.8%) |
Jun 2019 | - | $48.52 M(-6.2%) |
Mar 2019 | - | $51.76 M(-16.0%) |
Dec 2018 | $61.64 M(-34.8%) | $61.64 M(-12.6%) |
Sep 2018 | - | $70.56 M(-10.5%) |
Jun 2018 | - | $78.85 M(-8.7%) |
Mar 2018 | - | $86.38 M(-8.6%) |
Dec 2017 | $94.49 M(+274.2%) | $94.49 M(+179.0%) |
Sep 2017 | - | $33.87 M(-2.4%) |
Jun 2017 | - | $34.71 M(+37.5%) |
Dec 2016 | $25.25 M(-63.4%) | $25.25 M |
Dec 2015 | $69.01 M | - |
FAQ
- What is Allena Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Allena Pharmaceuticals?
- What is Allena Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Allena Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Allena Pharmaceuticals?
- What is Allena Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Allena Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ALNA is $29.99 M
What is the all time high annual cash & cash equivalents for Allena Pharmaceuticals?
Allena Pharmaceuticals all-time high annual cash & cash equivalents is $94.49 M
What is Allena Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ALNA annual cash & cash equivalents has changed by -$5.05 M (-14.42%)
What is Allena Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ALNA is $6.59 M
What is the all time high quarterly cash and cash equivalents for Allena Pharmaceuticals?
Allena Pharmaceuticals all-time high quarterly cash and cash equivalents is $94.49 M
What is Allena Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ALNA quarterly cash and cash equivalents has changed by -$20.07 M (-75.28%)